MARY MAY: Open Payments
NPI 1255066452 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$276 in 18 payments from 10 companies in 2025. Trend: 2023 $239 · 2024 $417 · 2025 $276
Food & beverage: $276
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 7 | $74 |
| MILLICENT US INC | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| SHIELD THERAPEUTICS INC | 1 | $25 |
| Exeltis, USA Inc. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Sage Therapeutics, LLC | 1 | $17 |
| Ethicon US, LLC | 1 | $15 |
| Organon LLC | 1 | $12 |
Products named: FEMLYV, ACCRUFER, SLYND, Veozah, Qelbree, ZURZUVAE, Lynkuet, Mirena.
Industry payments across AL — which companies pay providers there.
